Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$50.38
+1.58%
Mkt Cap $4.76B
Analyst Ratings
Buy
23
Hold
0
Sell
0
Price Target (24 analysts)
$70.60
Range $49.00 – $89.00
Implied Upside
+40.1%
Consensus $70.60 vs current $50.38
NASDAQ·Healthcare·Biotechnology
$50.38
+1.58%
Mkt Cap $4.76B
Buy
23
Hold
0
Sell
0
Price Target (24 analysts)
$70.60
Range $49.00 – $89.00
+40.1%
Consensus $70.60 vs current $50.38